Scan to Download Gate App
qrCode
More Download Options
Don't remind me again today

AstraZeneca's breast cancer drug Enhertu shows better efficacy in preventing recurrence compared to competitors and is expected to cure early-stage patients.

Jin10 reported on October 20 that AstraZeneca and Japan's Daiichi Sankyo's cancer drug Enhertu has shown better treatment outcomes for early breast cancer patients. In two key trials presented at the European Society for Medical Oncology meeting held in Berlin last weekend, Enhertu outperformed Roche's Kadcyla in preventing disease recurrence, and was more effective when used prior to surgery.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)